Holen Sie sich die Stockscreener-App
71.22
9.82%
6.37
Handel nachbörslich:
71.50
0.28
+0.39%
Schlusskurs vom Vortag:
$64.85
Offen:
$66.12
24-Stunden-Volumen:
985.11K
Relative Volume:
1.22
Marktkapitalisierung:
$1.81B
Einnahmen:
$302.00K
Nettoeinkommen (Verlust:
$-117.10M
KGV:
-6.3989
EPS:
-11.13
Netto-Cashflow:
$-129.13M
1W Leistung:
+9.79%
1M Leistung:
+12.62%
6M Leistung:
+213.05%
1J Leistung:
+512.91%
1-Tages-Spanne:
$65.80
$71.49
1-Wochen-Bereich:
$63.50
$71.49
52-Wochen-Spanne:
$10.14
$71.49
Cidara Therapeutics Inc Stock (CDTX) Company Profile
Firmenname
Cidara Therapeutics Inc
Sektor
Branche
Telefon
858-752-6170
Adresse
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
Vergleichen Sie CDTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CDTX
Cidara Therapeutics Inc
|
71.22 | 1.64B | 302.00K | -117.10M | -129.13M | -11.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.11 | 99.26B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
598.71 | 62.06B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.17 | 59.21B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
731.77 | 44.94B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.89 | 36.57B | 3.81B | -644.79M | -669.77M | -6.24 |
Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-03-12 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-01-27 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2024-12-13 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-11-08 | Eingeleitet | Guggenheim | Buy |
| 2024-08-14 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2021-12-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-09-22 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2021-03-04 | Eingeleitet | Aegis Capital | Buy |
| 2019-09-04 | Hochstufung | Wedbush | Neutral → Outperform |
| 2018-07-26 | Eingeleitet | Citigroup | Buy |
| 2017-04-21 | Eingeleitet | Raymond James | Strong Buy |
| 2017-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2017-04-12 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2017-04-11 | Fortgesetzt | Wedbush | Outperform |
| 2017-02-22 | Bestätigt | H.C. Wainwright | Buy |
| 2017-02-22 | Hochstufung | WBB Securities | Sell → Hold |
| 2016-12-21 | Fortgesetzt | Leerink Partners | Outperform |
| 2016-12-19 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-09-23 | Herabstufung | WBB Securities | Hold → Sell |
| 2015-10-09 | Hochstufung | WBB Securities | Sell → Hold |
| 2015-05-11 | Eingeleitet | Jefferies | Buy |
| 2015-05-11 | Eingeleitet | Leerink Partners | Outperform |
| 2015-05-11 | Eingeleitet | Needham | Buy |
| 2015-05-11 | Eingeleitet | Wedbush | Outperform |
| 2015-04-23 | Eingeleitet | WBB Securities | Sell |
Alle ansehen
Cidara Therapeutics Inc Aktie (CDTX) Neueste Nachrichten
Cidara Therapeutics (NASDAQ:CDTX) Insider Nicole Negar Davarpanah Sells 474 Shares - MarketBeat
Cidara Therapeutics stock hits 52-week high at 69.42 USD By Investing.com - Investing.com Australia
Is Cidara Therapeutics Inc. reversing from oversold territory2025 Key Highlights & Technical Pattern Based Signals - newser.com
Has Cidara Therapeutics Inc. found a price floorMarket Growth Report & Community Consensus Stock Picks - newser.com
Cidara Therapeutics stock hits 52-week high at 69.42 USD - Investing.com
Quarterly Earnings: How cyclical is Complete Solaria Incs revenue stream2025 Market Trends & Real-Time Buy Signal Notifications - خودرو بانک
Can a trend reversal in Cidara Therapeutics Inc. lead to recoveryGold Moves & Smart Swing Trading Techniques - newser.com
Cidara’s influenza preventative shows promising results in trials - Investing.com
Cidara Therapeutics (CDTX) Unveils Promising Data on Influenza D - GuruFocus
Cidara shares phase 2b CD388 data, H5N1 preclinical results at ISRV's 8th AVG & 3rd IMRP 2025 meeting - MarketScreener
Cidara Shares Phase 2B CD388 Data, H5N1 Preclinical Results At ISRV’s 8th AVG & 3rd IMRP 2025 Meeting - TradingView
Cidara Therapeutics Presents Data on CD388 from its Phase 2b NAVIGATE Trial and Preclinical Studies Against H5N1 at ISRV’s 8th AVG and 3rd IMRP 2025 Meeting - The Manila Times
Cidara Therapeutics Presents CD388 Efficacy and Safety Data from NAVIGATE Phase 2b Trial at ISRV Conference - Quiver Quantitative
Cidara Therapeutics Presents Data on CD388 from its Phase - GlobeNewswire
100% Survival Against Deadly H5N1 Bird Flu: Cidara's CD388 Drug Shows Breakthrough Protection in Study - Stock Titan
Will Cidara Therapeutics Inc. benefit from macro trends2025 Top Decliners & Intraday High Probability Alerts - newser.com
Published on: 2025-09-17 01:30:58 - khodrobank.com
Published on: 2025-09-17 00:05:36 - khodrobank.com
Growth Review: Is Cidara Therapeutics Inc. still a buy after recent gainsEarnings Miss & Technical Analysis for Trade Confirmation - خودرو بانک
Volume Recap: Can Cidara Therapeutics Inc. weather a recessionMarket Sentiment Review & Consistent Profit Trade Alerts - خودرو بانک
Aug Ideas: Will Cidara Therapeutics Inc stock go up in YEARMarket Performance Report & Safe Swing Trade Setup Alerts - khodrobank.com
Bank Watch: How sensitive is Cidara Therapeutics Inc to inflationJuly 2025 Setups & Free Long-Term Investment Growth Plans - خودرو بانک
Bearish Setup: Will Cidara Therapeutics Inc benefit from sector rotationJuly 2025 Gainers & Weekly Consistent Profit Watchlists - khodrobank.com
Whale Trades: Is Atlas Corp in a consolidation phase2025 Risk Factors & Reliable Entry Point Alerts - خودرو بانک
How institutional ownership impacts Cidara Therapeutics Inc. stockMarket Activity Recap & Safe Entry Trade Reports - newser.com
Buy Signal: Is Ascent Industries Co. a good stock for dollar cost averagingProduct Launch & Intraday High Probability Alerts - خودرو بانک
Institution Moves: Can Cidara Therapeutics Inc. weather a recession2025 Sector Review & Daily Chart Pattern Signals - khodrobank.com
Published on: 2025-09-16 05:54:13 - خودرو بانک
Influenza A Market: Epidemiology, Therapies, Companies, DelveInsight | Cidara Therapeutics, SAb Biotherapeutics, FluGen, Moderna, Vir Biotechnology, Vaxart - Barchart.com
Cidara therapeutics CMO Davarpanah sells $29,796 in stock - Investing.com India
What earnings revisions data tells us about Cidara Therapeutics Inc.2025 Market Overview & Technical Confirmation Alerts - newser.com
Market Rankings: Is Cidara Therapeutics Inc in a consolidation phaseJuly 2025 Action & Fast Gain Stock Tips - khodrobank.com
Cidara Therapeutics Inc. stock volume spike explainedQuarterly Profit Summary & Real-Time Buy Zone Alerts - newser.com
How buybacks impact Cidara Therapeutics Inc. stock valueMarket Growth Summary & Weekly Return Optimization Plans - baoquankhu1.vn
American Century Companies Inc. Buys Shares of 10,409 Cidara Therapeutics, Inc. $CDTX - MarketBeat
Adage Capital Partners GP L.L.C. Has $21.33 Million Holdings in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Cidara Therapeutics, Inc. $CDTX Shares Sold by Checkpoint Capital L.P. - MarketBeat
How does Cidara Therapeutics Inc. compare to its peers2025 Trading Recap & Momentum Based Trading Ideas - Lancaster City Council
OMERS ADMINISTRATION Corp Boosts Stock Holdings in Cidara Therapeutics, Inc. $CDTX - MarketBeat
Bollinger Bands Show Potential Breakout in Cidara Therapeutics Inc.2025 Performance Recap & Accurate Intraday Trading Signals - beatles.ru
Cidara Therapeutics: Promising Trials Amidst Financial Challenges - MSN
Is Cidara Therapeutics Inc. still a buy after recent gainsJuly 2025 Selloffs & Daily Momentum Trading Reports - 뉴스영
Watch for Bullish Crossover in Cidara Therapeutics Inc.2025 Short Interest & Long-Term Safe Return Strategies - beatles.ru
Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Consensus Recommendation of "Buy" from Brokerages - MarketBeat
Vestal Point Capital LP Buys Shares of 504,542 Cidara Therapeutics, Inc. $CDTX - MarketBeat
Cidara Therapeutics, Inc. $CDTX Shares Sold by ADAR1 Capital Management LLC - MarketBeat
Relative strength of Cidara Therapeutics Inc. in sector analysisJuly 2025 Decliners & Expert Verified Stock Movement Alerts - Newser
Cidara Therapeutics Inc. stock daily chart insightsMarket Volume Report & Capital Efficient Trade Techniques - Newser
Pattern recognition hints at Cidara Therapeutics Inc. upsideBull Run & Daily Stock Momentum Reports - Newser
Is Cidara Therapeutics Inc. stock heavily shortedExit Point & Accurate Entry and Exit Point Alerts - خودرو بانک
Can Cidara Therapeutics Inc. expand its profit marginsQuarterly Portfolio Review & Smart Money Movement Alerts - خودرو بانک
Finanzdaten der Cidara Therapeutics Inc-Aktie (CDTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.25%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):